The Lazzaro Spallanzani National Institute for Infectious Diseases (Italian: Istituto nazionale per le malattie infettive "L. Spallanzani") is an infectious disease hospital in the Italian city of Rome. The institute is named for the eighteenth-century Italian biologist Lazzaro Spallanzani.[citation needed]
It is the Italian national reference center for Ebola patients.[1]
During the COVID-19 pandemic, the Spallanzani Institute was the first research centre in Europe to isolate the genomic sequence of SARS-CoV-2 and upload it to GenBank.[2] The team was composed of Maria Rosaria Capobianchi, Francesca Colavita, and Concetta Castilletti.[3]
The institute is working with biotech company ReiThera to test a COVID-19 vaccine candidate called GRAd-COV2, which is based on a modified gorilla adenovirus vector.[4]
References
- ^ "Nurse in Italy tests positive for Ebola; was in Sierra Leone". U-T San Diego. Retrieved 13 May 2015.
- ^ "Una speranza dall'Istituto Spallanzani di Roma: "Abbiamo isolato il coronavirus"". La Stampa (in Italian). Retrieved 2 February 2020.
- ^ "Le tre ricercatrici che hanno isolato il Coronavirus allo Spallanzani di Roma". Sky TG24 (in Italian). Retrieved 2 February 2020.
- ^ "New ReiThera vaccine safe, response peak at 4 wks". ANSA. 5 January 2021.
External links
| International | |
|---|---|
| National | |
41°51′58″N 12°27′27″E / 41.8662°N 12.4576°E